NAMENDA Â® (memantine hydrochloride) is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. NAMENDA is available by prescription only. There is no evidence that NAMENDA prevents or slows the underlying disease process in patients with Alzheimer's disease. The most common side effects associated with NAMENDA treatment are dizziness, confusion, headache, and constipation. This is not a complete list of side effects. Please see full Prescribing Information.